Portolano Cavallo

Life Sciences


Portolano Cavallo Life Sciences Blog
18 Apr
Chatbots and virtual assistants: How might they be used in pharmaceuticals?
When browsing the web and using smartphone applications, users increasingly encounter chatbots and virtual assistants (some more sophisticated than others) that interact with them and generate conversations This is in part due to the development and implementation of artificial intelligence systems.
15 Apr
“Pharmacy of Services”: Simplification Decree expands the range of healthcare and telemedicine services pharmacies can provide
The new draft of the Simplification Decree, recently approved by the Council of Ministers, significantly expands the range of services that can be provided by pharmacies as part of the National Health Service.
12 Apr
Digitization of tender procedures and new certified platforms: Operability and current issues
When fully implemented, the provisions of the new Public Procurement Code on the digitization of tender procedures will cover digital management of all phases of the procedure, from planning and design to the award and execution of contracts.
4 Apr
Online sale of medicines without a prescription: The Court of Justice of the European Union approves intermediary sites
In its February 29, 2024 ruling, the Court of Justice of the European Union intervened on a major issue for the online medicine sales industry, paving the way for the entry of intermediary platforms.
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

October 6, 2023
CBD products: the Administrative Court suspended until October 24 the recent Decree of the Italian Ministry of Health listing cannabidiol for oral use among narcotic drugs, due to the lack o...
October 4, 2023
The Guidelines for regulating contractual relations between universities and research institutes and private sponsors were adopted by the relevant Italian Ministries following the amendment ...
September 21, 2023
CBS products: from September 20th, compositions for oral administration of cannabidiol obtained from Cannabis sativa extracts shall be considered as narcotic drugs in Italy, as they have bee...
July 27, 2023
Payback on medical devices: Italian government announces extension of payment deadline to October 30, 2023
July 21, 2023
On July 21, 2023, the Italian Ministry of Health published new guidelines on health advertising of self-medication drugs (OTC) and non-prescription drugs (SOP), including advertising on new ...
Search by...
Follow us on
Follow us on